Details of the Drug Reposition

General Information of This Drug (ID: DMLA8H3)

Drug Name
LX2931   DMLA8H3
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hereditary acantholytic dermatoses DISI4ILV EC20.2 Phase 2 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00903383) Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate. U.S. National Institutes of Health.